PCM
ARDS

Perritt Capital Management’s Aridis Pharmaceuticals Inc. Common Stock ARDS Stock Holding History

Perritt Capital Management’s Portfolio ARDS Stock Details ARDS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-24,000
Closed -$42K – 202
2022
Q1 		$42K Hold
24,000
– – 0.02% 193
2021
Q4 		$56K Buy
24,000
+8,000
+50% +$22.8K 0.03% 199
2021
Q3 		$59K Hold
16,000
– – 0.03% 194
2021
Q2 		$118K Buy
16,000
+5,900
+58% +$36.9K 0.06% 195
2021
Q1 		$60K Buy
+10,100
New +$68.3K 0.03% 194

Other funds holding ARDS

Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RAM
Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MWM
Minot Wealth Management Westwood, Massachusetts $389M AUM 3.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Perritt Capital Management's ARDS Position: Q2 2022 in Review

Perritt Capital Management sold out of Aridis Pharmaceuticals Inc. Common Stock (ARDS) in Q2 2022, closing a stake of 24,000 shares — an estimated $42K sold.

Perritt Capital Management first reported a position in ARDS in Q1 2021 and held it in 5 quarters. The position peaked at $118K in Q2 2021. 19 funds tracked by Wall St. Rank hold ARDS as of Q2 2022.

  • Perritt Capital Management reported no remaining Aridis Pharmaceuticals Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Perritt Capital Management sold 24,000 Aridis Pharmaceuticals Inc. Common Stock shares in Q2 2022, an estimated $42K.
  • Perritt Capital Management first reported a position in Aridis Pharmaceuticals Inc. Common Stock in Q1 2021 and held it in 5 quarters.
  • Perritt Capital Management's Aridis Pharmaceuticals Inc. Common Stock position peaked at $118K in Q2 2021.
  • 19 funds tracked by Wall St. Rank held Aridis Pharmaceuticals Inc. Common Stock as of Q2 2022.

Based on Perritt Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.